GLP-1 (7-37) CAS 106612-94-6 reduce blood sugar in a glucose-dependentmanner without any adverse reactions

GLP-1 (7-37) CAS 106612-94-6 Lower blood glucose levels without any adverse effects

Product Name: H-HIS-ALA-GLU-GLY-THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARG-GLY-OH/ GLP-1 (7-37)
Synonyms: Insulinotropin (human);Peptide GLP-1 (human glucose-lowering peptide-1);Glp-I (7-37);Glucagon like peptide I (7-37);Glucagon-related peptide (oncorhynchus kisutch), 3-L-glutamic acid-6-L-phenylalanine-9-L-aspartic acid-12-L-serine-15-L-glutamic acid-16-glycine-21-L-isoleucine-24-L-alanine-27-L-valine-28-L-lysine-31-glycine-;Tglp-1;GLP-1, 7-37;Preproglucagon 78-108
CAS: 106612-94-6
MF: C151H228N40O47
MW: 3355.67
EINECS:
Product Categories: peptides pharm;peptide
Mol File: 106612-94-6.mol

GLP-1 (7-37) CAS 106612-94-6 Chemical Properties
density 1.48±0.1 g/cm3(Predicted)
storage temp. −20°C
Water Solubility Soluble in water at 2mg/ml
CAS DataBase Reference 106612-94-6

Function and Application of GLP-1 (7-37) CAS 106612-94-6
Humanglucagon-likepPeptide -1(GLP-1)is a small polypeptide with 30 amino acids,which is potent to reduce blood sugar in a glucose-dependentmanner without any adverse reactions,in addition to the multiple functions of GLP-1,it becomes a research hotspot in curing the diabetesII. However,to realize its clinical application,it is urgent to solve the problem of its short half-life in vivo. Hence,the reviews of the latestprogress on the research and clinical application of GLP-1 in China and abroad on the basis of previous studies will provide reference for theresearchers and medical workers in the development of GLP-1 relevant drugs.